Why the study?
Does targeted genetic mutagenesis of candidate genes reduce hypertension and renal injury in the Dahl S rat model?
Does targeted genetic mutagenesis of candidate genes reduce hypertension and renal injury in the Dahl S rat model?
Targeted genetic mutagenesis in the Dahl S rat validates human candidate genes for hypertension and provides a model to explore novel pathogenic mechanisms and therapeutic targets.
Human genetic linkage and association studies have nominated many genes as possible contributors to disease. Mutating or deleting these genes in a relevant disease model can validate their association with disease and potentially uncover novel mechanisms of pathogenesis. Targeted genetic mutagenesis has only recently been developed in the rat, and this technique has been applied in the Dahl salt-sensitive (S) rat to investigate human candidate genes associated with hypertension. This mini-review communicates the findings of these studies and displays how targeted genetic mutagenesis may contribute to the discovery of novel therapies for patients.
No takes yet. Share an insight, caveat, or question.
Rudemiller et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: